Hepatitis C medicines for NHS Wales

6 November 2026 at 12:00; time zone not stated
Time not stated
Contract value
£6,549,650.36

Estimated total contract value, excluding VAT

Contract period
1 May 2027–30 April 2029, with an extension option of up to two years
Published
October 6, 2026

Official Sell2Wales public notice

Overview

NHS Wales is seeking antiviral medicines for hepatitis C treatment.

Information based on the public notice

What the buyer needs

The open procedure seeks antiviral medicines for treating hepatitis C for NHS Wales. The estimated contract value is £6,549,650.36 excluding VAT. The initial term is 1 May 2027 to 30 April 2029, with an extension option of up to two years. Price carries 85% weighting, environmental/social value 15%, and product quality is pass/fail.

Tender details

Buyer
NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust)
Country
United Kingdom
Procedure
UK4
Classification
Pharmaceuticals
Notice reference
OCT665369 · PHA-FTS-63590
estimated value
£6,549,650.36 excluding VAT
term
1 May 2027–30 April 2029
extensions
Up to two years
deadline
6 November 2026 at 12:00 (time zone not stated)

What to check in the tender documents

  • The public notice refers participation conditions and product specifications to separate tender documents, which were not accessed.
Get started with Ziva

Original notice

Read the original description

Hepatitis C Medicines

Summary OCID: ocds-h6vhtk-066b74 Published by: NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) Authority ID: AA0221 Publication date: 07 October 2026 Deadline date: 06 November 2026 Notice type: UK4 Has documents: No Has SPD: No Has Carbon Reduction Plan: N/A Abstract This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales. Procurement reference PHA-FTS-63590 Procurement description This tender is for the provision of antiviral medicines for the treatment of Hepatitis C (HCV) to NHS Wales. Main category Goods Delivery regions UKL - Wales Total value (estimated, excluding VAT) 6549650.36 GBP to 6549650.36GBP Contract dates (estimated) 01 May 2027, 00:00AM to 30 April 2029, 23:59PM Extension end date (if all the extensions are used): 30 April 2031 Procedure type Open procedure CPV classifications 33600000 - Pharmaceutical products Delivery regions UKL - Wales Lot value (estimated) 6549650.36 GBP Excluding VAT 7859580.43 GBP Including VAT Contract start date (estimated) 01 May 2027, 00:00AM Contract end date (estimated) 30 April 2029, 23:59PM Extension end date (estimated) 30 April 2031, 23:59PM Can the contract be extended? Yes Description of extensions Extension option of up to 2 years available Participation Conditions Economic Conditions of participation As per the tender documents Conditions Economic Conditions of participation As per the tender documents Award criteria Type: quality Name Product Quality/Acceptability Description Pass/Fail Weighting: 1 Weighting type: order Type: cost Name Financial (Overall Cost of Contract) Description Weighting: 85 Weighting: 2 Weighting type: order Type: quality Name Environmental/Social Value/Community Benefits Description Weighting: 15 Weighting: 3 Weighting type: order Tender submission deadline 06 November 2026, 12:00PM Enquiry deadline 02 November 2026, 12:00PM Date of award of contract 26 February 2027, 23:59PM Submission address and any special instructions https://etenderwales.ukp.app.jaggaer.com/home.html May tenders be submitted electronically? Yes Languages that may be used for submission English

Official source: Official Sell2Wales public notice ↗